Earnings Per Share

9 Months Ended

Sep. 30, 2020

Earnings Per Share [Abstract]

Earnings Per Share [Text Block]

Note 12 – Earnings Per Share

The following table summarizes earnings per share calculations for the three and nine months ended September 30, 2020 and

2019:

Three Months Ended 

Nine Months Ended

September 30,

September 30,

2020

2019

2020

2019

Basic earnings (loss) per common share

Net income (loss) attributable to Quaker Chemical Corporation

$ 

27,304

$

(13,053)

$ 

(8,812)

$

16,382

Less: (income) loss allocated to participating securities

(113)

46

44

(40)

Net income (loss) available to common shareholders

$ 

27,191

$

(13,007)

$ 

(8,768)

$

16,342

Basic weighted average common shares outstanding

17,743,538

16,185,724

17,704,662

14,271,121

Basic earnings (loss) per common share

$

1.53

$

(0.80)

$

(0.50)

$

1.15

Diluted earnings (loss) per common share

Net income (loss) attributable to Quaker Chemical Corporation

$

27,304

$

(13,053)

$ 

(8,812)

$

16,382

Less: (income) loss allocated to participating securities

(113)

46

44

(40)

Net income (loss) available to common shareholders

$

27,191

$

(13,007)

$

(8,768)

$

16,342

Basic weighted average common shares outstanding

17,743,538

16,185,724

17,704,662

14,271,121

Effect of dilutive securities

57,327

—

—

42,850

Diluted weighted average common shares outstanding

17,800,865

16,185,724

17,704,662

14,313,971

Diluted earnings (loss) per common share

$

1.53

$

(0.80)

$

(0.50)

$

1.14

During the third quarter of 2019, the Company issued approximately

4.3

 million shares of common stock, comprising

24.5

% of

the common stock of the Company immediately after the closing, as a component of the consideration transferred in the Combination.

Certain stock options and restricted stock units are not included in the diluted earnings (loss) per share calculation because the effect

would have been anti-dilutive. All of the Company’s potentially dilutive shares for the nine months ended September 30, 2020 and

the three months ended September 30, 2019 are anti-dilutive and not included in the dilutive earnings (loss) per share calculations

because of the Company’s net loss for the periods. There were

no

 anti-dilutive shares excluded from the diluted earnings per share

calculations for the three months ending September 30, 2020 and the nine months ended September 30, 2019.